ALKS, 2/20-3/18, -9.5% profitOn 2/15/2024, Alkermes (ALKS) reported earnings of $0.59 per share on revenue of $377.48 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.54 per share on revenue of $362.02 million. Longby 1hour_trading0
ALKS - Ascending Triangle Breakout ExpectationAn example of an Ascending Triangle on a Monthly timeframe Ascending Triangles tend to break out bullishly which I have shown with the bars pattern tool A big Breakout for a completion of a big chart pattern Bullish by Bixley2
Buy ALKS in US stock market 15/8/2022You can buy it Target 28.36 stop loss 24.56 money management is your responsibility . good luckby amr_youssef21
$ALKS RS vs MarketBiotech that's showing tremendous relative strength against this bear market. Worth putting on your watchlist.Longby TaPlot10
Alkermes Receives FDA Fast Track Designation for Nemvaleukin AlfALKS: Alkermes plc 2021-10-25 07:00:00 Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian CancerLongby RocketTickers110
Breakout Pending on ALKS. Long !ALKS is about to breakout. I will be long some before the actual break occurs. Once break occurs I am expecting a run to at least 30.0. Longby LiquidityTrackerUpdated 222
ALKERMES Analysis DailyHey traders, ALKERMES is in a bearish fake dynamic with a low volume of issued sales and refusal of buyers on the shadow. On the TIMEFRAME M1 we observed a tombstone with a high volume of purchases made it will breakout its consolidation zone down. To go on its last precedent lower and turn around big propability to breakout the price. Subsequently the VWAP will be broken to test the top of the consolidation zone and join another. If buyers get into transactions we can still breakout the area and land on significant resistance compared to ANDREWS PITCHFORK See MULTI TIMEFRAME H4 H1 for adjustment. No objective on the middle of the MEDIAN. Please LIKE & FOLLOW, thank you! Shortby stephanelibatd1
ALKS: Ascending Triangle, ConfirmedAscending Triangle, Confirmed Pros R/R above7 Descending Volume PPS above 50M and 200MA Cons 200MA descending ATR flat 250RSI below 50 Targets: PT1 = 20,96 PT2 = 23,43 PT3 = 24,79Longby LeLaf2
Alkermes Plc on watchlist for reversal Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include the brands Aristada and Vivitrol. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.by RedHotStocks23
ALKS BUY 03.09.2019BUY signal at 20.98 $ Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. If you want to see more history of this strategy, I will able to show you if you request me. ATTENTION this strategy may has downtrend about 20%, so you can split your buy order, that you have not big downtrend. __________________________________________________________________________ You can use the signals independently or like indicator of trends together with other indicators in your trading strategy. Know that the success of your strategy that based on those signals depends from your money management and the additional conditions that you make in these strategies. You use these signals inside your strategies at your own risk. The chart shows the last trades on the product + the last signal. I have several strategies for different products, and I want to show you proof of it works on history, and you will be able to see it, when returns to that profile. Therefore, subscribe and watch for that profile. The signals rare but useful.Longby price_and_time5
ALKS Daily, Basing / AccumulationNice volume bars this past week, appears to be consolidating for a move up. Looking at August calls in this name. Longby UnknownUnicorn50135852
$ALKM Investors are exiting on mass. Short to $28 minimum. Investors once again are disappointing by the lack of progress in Alkermes Plc and have hit the sell button today. Indications are that the sell side will continue, technical levels have been broken and there is not great support under to halt the action . Shortby RedHotStocks5
Break high ALKScase 1. break high Follow call 78.65 cut 78.50 exit short term 3% 81.50 long term fibo 161.8% 87 case 2. Throw back test break high 74.60 call exit 78.65 cut 74.50by NopChai1
ALKS up against top of channel, plus horizontal resistanceALKS broke rising trendline, broke horizontal around 66.50, and has been trading around horizontal at ~62.50. Will need to drop from here to stay in the channel.Shortby EdO'Donnell1